CLINICAL_TRIALS
trial_result
· 2009-07-17
Clinical Trial Update: Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia [Phase 4]
Summary
Phase 4 trial assessing whether ramelteon facilitates discontinuation of zolpidem (≥10 mg) in adults with chronic insomnia; results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Chronic Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2009-07-17